Ethiopia vs Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Ethiopia
81.0%
in 2025
Ireland
81.0%
in 2025
Ethiopia rank
111th
Ireland rank
111th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Ethiopia
- Ireland
How they compare
Ethiopia currently reports 81.0% against 81.0% in Ireland, a difference of 0.0%.
Across all 18 years both countries report, Ireland has been ahead every year.
Ethiopia ranks 111th and Ireland ranks 111th of 192 countries.
Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 46.4% | 85.7% | 39.3% | Ireland |
| 2020s | 73.7% | 84.0% | 10.3% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Ethiopia or Ireland?
- Ethiopia, at 81.0% against 81.0% in Ireland as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Ethiopia and Ireland?
- 0.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Ireland?
- 18 years are reported by both, from 2008 to 2025.
- How do Ethiopia and Ireland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Ethiopia ranks 111th and Ireland ranks 111th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.